Search for: "CASE V. HATCH"
Results 1 - 20
of 1,018
Sort by Relevance
|
Sort by Date
15 May 2024, 6:32 am
Third, these documents make clear that the scheme was not—as now alleged by Trump’s defenders—a contingency plan in case courts overturned election results. [read post]
18 Apr 2024, 7:49 am
The worst-case scenario is easy to envision based on opinions to date. [read post]
3 Apr 2024, 8:18 pm
§ 271(e)(1) was the occasion for the Federal Circuit to illustrate the continued debate over the scope of the safe harbor enacted as part of the Hatch-Waxman Act in Edwards Lifesciences Corp. v. [read post]
3 Apr 2024, 1:07 pm
Health & Welfare Fund v. [read post]
1 Apr 2024, 10:58 am
., Inc. v. [read post]
20 Mar 2024, 8:24 am
Castillo v. [read post]
18 Mar 2024, 7:44 am
Zittrain (or “JZ” as he’s affectionately known) had hatched the idea for the project and started working out a skeletal framework for a potential deal. [read post]
14 Mar 2024, 1:48 pm
There's a California Supreme Court case called People v. [read post]
13 Mar 2024, 7:24 pm
” (see also Hoechst-Roussel Pharms., Inc. v. [read post]
27 Feb 2024, 7:08 pm
The PTO’s not-even-specious-argument, citing what certainly appears to us to be absolutely irrelevant case law, such as Novartis AG v. [read post]
15 Feb 2024, 3:33 pm
Bose Corp. v. [read post]
2 Feb 2024, 6:51 am
Supreme Court mishandles the pending case of Trump v. [read post]
2 Feb 2024, 2:30 am
Anderson case. [read post]
23 Jan 2024, 3:43 am
., v. [read post]
19 Jan 2024, 12:15 am
Although commentators have handicapped the case differently, it is possible that the Supreme Court will overturn the deferential standard of judicial review of agency interpretations adopted in Chevron, U.S.A., Inc. v. [read post]
18 Jan 2024, 9:16 am
Lundbeck A/S, et al. v. [read post]
27 Dec 2023, 2:20 am
Antero Resources Corp . v. [read post]
18 Dec 2023, 10:00 pm
This video discusses the evidence the court relied upon in finding induced infringement in this case and lessons for avoiding infringement. [read post]
11 Dec 2023, 7:43 am
The accused infringer in this Hatch-Waxman case argued that up to 29% of the total use of the drug in question was off-label and noninfringing, and the patent owner conceded that this noninfringing off-label use was possibly as high as 8%. [read post]
7 Dec 2023, 1:47 pm
I want to note here that the facts in this case are different from prior carve-out cases such as GlaxoSmithKline LLC v. [read post]